Chinese link-up for first aid developer
Alltracel, which is quoted on London’s Alternative Investment Market (AIM), will co-operate with the Chinese firm to sell its anti-bleeding products in China and other markets.
Yunnan Baiyao is one of the biggest Chinese medicine companies and is listed on Shenzhen’s stock exchange with a market capitalisation of about €500m.





